Donor Heart Biology: Cardiac vs Brain Death 08/02/26
Welcome to Cardiology Today â Recorded August 02, 2026. This episode summarizes 5 key cardiology studies on topics like respiratory support and registry analysis. Key takeaway: Donor Heart Biology: Cardiac vs Brain Death.
Article Links:
Article 1: Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 2: Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 3: Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 4: The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Article 5: Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death. (The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation)
Full episode page: https://podcast.explainheart.com/podcast/donor-heart-biology-cardiac-vs-brain-death-08-02-26/
đ Featured Articles
Article 1: Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41951134
Summary: A retrospective analysis utilizing the Cardiogenic Shock Working Group registry provided comparative data on patient trajectories and outcomes in cardiogenic shock. The study specifically compared individuals receiving heart replacement therapies versus those who did not during their index hospitalization. Cardiogenic shock severity was characterized using Society for Cardiovascular Angiography and Interventions stages, machine learning-derived phenotypes, and the Comorbidity Risk Index. This analysis yielded foundational comparative insights into patient courses under different management strategies for severe cardiogenic shock.
Article 2: Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41949527
Summary: To address suboptimal cannulation for durable veno-venous extracorporeal membrane oxygenation support in end-stage chronic obstructive pulmonary disease, four novel central cannulation strategies were designed, fabricated, and evaluated. Current configurations for long-term respiratory support are suboptimal, prompting the development of these new approaches for durable artificial lung therapies. The evaluation provided crucial insights into improved cannulation configurations, offering critical alternatives for chronic obstructive pulmonary disease patients facing donor lung scarcity. This work advances long-term physiological support for patients requiring prolonged respiratory assistance.
Article 3: Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41949525
Summary: This study investigated single-beat right ventricular-pulmonary artery coupling using elastance-based indices to identify residual heart failure risk in 70 adults with HeartMate 3 left ventricular assist devices. Patients underwent pre-discharge right heart catheterization after optimized device support. The findings demonstrated how right ventricular-pulmonary artery interaction, measured via specific indices, correlates with the presence of ongoing heart failure despite left ventricular assist device implantation. This work provides new understanding of the mechanisms contributing to residual heart failure in this population.
Article 4: The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41935548
Summary: The A. S. S. I. S. T. chronic lung allograft dysfunction study, a multicenter, phase two, double-blind, randomized controlled trial, demonstrated the impact of intravenous allogenic bone marrow-derived mesenchymal stromal cells in lung transplant recipients with new-onset chronic lung allograft dysfunction. This trial, involving participants aged 18 years or older more than six months post-transplant, focused on those with a persistent fall in forced expiratory volume in one second. The findings established the safety and initial efficacy profile of mesenchymal stromal cells as a therapeutic strategy for this primary limitation to long-term survival after lung transplantation. This work provides evidence for the use of mesenchymal stromal cells in mitigating chronic lung allograft dysfunction.
Article 5: Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41881141
Summary: This study performed single-nuclei ribonucleic acid sequencing and metabolomics on the human left ventricle, revealing fundamentally different cardiac biology between hearts donated after brain death versus cardiac death. The data demonstrated that hearts donated after cardiac death are specifically marked by ischemic metabolic responses and the generation of oxidative substances. These findings provide critical molecular insights into the distinct physiological states of donor hearts, which can inform preservation strategies. This differential transcriptomic and metabolomic landscape highlights the need for tailored approaches in evaluating and managing hearts from different donation types for transplantation.
đ Transcript
Today’s date is August 02, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Trajectories and outcomes in patients with cardiogenic shock receiving heart replacement therapies. A retrospective analysis utilizing the Cardiogenic Shock Working Group registry provided comparative data on patient trajectories and outcomes in cardiogenic shock. The study specifically compared individuals receiving heart replacement therapies versus those who did not during their index hospitalization. Cardiogenic shock severity was characterized using Society for Cardiovascular Angiography and Interventions stages, machine learning-derived phenotypes, and the Comorbidity Risk Index. This analysis yielded foundational comparative insights into patient courses under different management strategies for severe cardiogenic shock.
Article number two. Determining an optimal central cannulation strategy for ambulatory veno-venous extracorporeal life support. To address suboptimal cannulation for durable veno-venous extracorporeal membrane oxygenation support in end-stage chronic obstructive pulmonary disease, four novel central cannulation strategies were designed, fabricated, and evaluated. Current configurations for long-term respiratory support are suboptimal, prompting the development of these new approaches for durable artificial lung therapies. The evaluation provided crucial insights into improved cannulation configurations, offering critical alternatives for chronic obstructive pulmonary disease patients facing donor lung scarcity. This work advances long-term physiological support for patients requiring prolonged respiratory assistance.
Article number three. Single-beat right ventricular-pulmonary artery coupling and residual heart failure in patients with a HeartMate 3 left ventricular assist device. This study investigated single-beat right ventricular-pulmonary artery coupling using elastance-based indices to identify residual heart failure risk in 70 adults with HeartMate 3 left ventricular assist devices. Patients underwent pre-discharge right heart catheterization after optimized device support. The findings demonstrated how right ventricular-pulmonary artery interaction, measured via specific indices, correlates with the presence of ongoing heart failure despite left ventricular assist device implantation. This work provides new understanding of the mechanisms contributing to residual heart failure in this population.
Article number four. The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction. The A. S. S. I. S. T. chronic lung allograft dysfunction study, a multicenter, phase two, double-blind, randomized controlled trial, demonstrated the impact of intravenous allogenic bone marrow-derived mesenchymal stromal cells in lung transplant recipients with new-onset chronic lung allograft dysfunction. This trial, involving participants aged 18 years or older more than six months post-transplant, focused on those with a persistent fall in forced expiratory volume in one second. The findings established the safety and initial efficacy profile of mesenchymal stromal cells as a therapeutic strategy for this primary limitation to long-term survival after lung transplantation. This work provides evidence for the use of mesenchymal stromal cells in mitigating chronic lung allograft dysfunction.
Article number five. Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death. This study performed single-nuclei ribonucleic acid sequencing and metabolomics on the human left ventricle, revealing fundamentally different cardiac biology between hearts donated after brain death versus cardiac death. The data demonstrated that hearts donated after cardiac death are specifically marked by ischemic metabolic responses and the generation of oxidative substances. These findings provide critical molecular insights into the distinct physiological states of donor hearts, which can inform preservation strategies. This differential transcriptomic and metabolomic landscape highlights the need for tailored approaches in evaluating and managing hearts from different donation types for transplantation.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
respiratory support, registry analysis, chronic lung allograft dysfunction, mesenchymal stromal cells, artificial lung therapies, metabolomics, brain death, heart replacement therapies, patient trajectories, residual heart failure, randomized controlled trial, veno-venous extracorporeal membrane oxygenation, lung transplantation, forced expiratory volume in one second, chronic obstructive pulmonary disease, HeartMate 3, transcriptomics, cardiogenic shock, left ventricular assist device, heart transplantation, cannulation strategies, right ventricular-pulmonary artery coupling, outcomes, donor heart preservation, right heart catheterization, cardiac death.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow